However, emerging analysis of CD4+CD25+CD127− and CD4+CD25+FOXP3+ cells suggest that the latter is a promising SLE activity indicator, especially in renal involvement, and may facilitate the detection of Treg subsets with clinical relevance [21]. Here, CD4 is linked to systemic lupus erythematosus.